MEDICREA moves to new headquarters in the Lyon area
MEDICREA specialises in bringing pre-operative digital planning and pre and post-operative analytical services to the world of complex spine. Through the lens of predictive medicine, MEDICREA leads the design, integrated manufacture, and distribution of 30+ FDA approved implant technologies, utilized in over 100k spinal surgeries worldwide to date. Operating in a $10 billion marketplace, MEDICREA is a Lyon-based SME with 150 employees worldwide, which includes 55 at its USA Corp. subsidiary in New York.
By leveraging its proprietary software analysis tools with big data and deep learning technologies supported by an expansive collection of clinical and scientific data, MEDICREA is well-placed to streamline the efficiency of spinal care, reducing procedural complications and limiting time spent in the O.R.
MEDICREA has just moved into new headquarters, located at the Vancia site in Rillieux-la-Pape, in the Lyon area. The new site unites Medicrea’s head office, previously at Neyron (Ain), with its production units, formerly in La Rochelle. The move also brings Medicrea closer to its strategic partners because Medicrea’s subcontractors, primarily in the mechanical field, are based in the Auvergne-Rhône-Alpes region.
The building’s 7315 sq. m. of floor space houses offices, a research and development centre, and an ultra-modern production workshop dedicated to developing and manufacturing 3D-printed patient-specific implants. The site will welcome 110 to 120 people and also boasts a sports hall, a cafeteria and leisure facilities (such as a vegetable garden and boules pitch). The group aims to build a new production unit and an additional laboratory within 5 or 6 years.
MEDICREA received support from Aderly throughout the various stages of the Lyon move, particularly in relocating staff from La Rochelle to Lyon. “Denys Sournac, the CEO, wanted time to be spent with everybody who was affected, to make sure they fully understood the move. We asked Aderly to help us support our employees,” said Fabrice Kilfiger, Finance Director. The agency also worked alongside Medicrea to recruit new employees to boost staff numbers. 30 jobs have to be created in the next 3 years.
Last year the company’s turnover was €24.2 million.
Medicrea is specialized in the manufacture of customized implants. It is the only company in the world to manufacture rods exactly matching the curvature of a patient’s spine based on x-rays. The first patient to benefit from an implant was from Lyon and it was performed in the Mermoz clinic in September 2013.
In summer 2016, Medicrea announced that €20 million in capital had been raised to secure the best possible launch for its customized rods in the United States and to introduce them to other international markets.